CLINICAL ROLE -
Pharmacy Week in Review: May 26, 2017
A look at the top stories in the world of pharmacy from last week.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Optimal Relationships Among Specialty Pharmacy Stakeholders
Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses how communication can be improved among manufacturers, pharmacy benefit managers, and specialty pharmacies.
How Can Pharmacies Prepare for Value-Based Health Systems?
In this clip, Crystal Lennartz, PharmD, MBA, Chief Pharmacist at Health Mart, discusses what steps pharmacies can take to prepare for value-based health systems.
How Can Independent Specialty Pharmacies Best Manage DIR Fees?
Cheryl Allen, vice president of Industry Relations at Diplomat, discusses the impact of direct and indirect remuneration fees on specialty pharmacy.
Cost vs Clinical Benefit of PCSK9 Inhibitors
Overcoming Access Barriers for PCSK9 Inhibitors
Access Considerations for PCSK9 Inhibitors
Role of Specialty Pharmacies for PCSK9 Inhibitors
Identifying Appropriate Patients for PCSK9 Inhibitors
Benefits of PCSK9 Inhibitors
Emergence of PCSK9 Inhibitors
Challenges in Treating Cardiovascular Disease
Multidisciplinary Management of Cardiovascular Disease
Clinical and Economic Burden of Cardiovascular Disease
Alternative Approaches to Prior Authorization in Specialty Pharmacy
Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses how specialty stakeholders can improve clinical and financial alignment.
Challenges in Treating Patients with Hepatitis C
In this clip, Jennifer Strohecker, PharmD, BCPS, Sr. Director MHI Pharmacy, Clinical Operations, Molina Healthcare, Inc. discusses the challenges involved in treating patients with hepatitis C.
Improving Patient Outcomes Through a High Touch Model of Care
In this clip, Jennifer Strohecker, PharmD, BCPS, who is Senior Director MHI Pharmacy, Clinical Operations, discusses a high touch model of care.
What Opportunities do Pharmacists Have to Influence Quality Measures?
At the 12th annual meeting of the Pharmacy Quality Alliance held recently in Baltimore, Maryland, several speakers shared ideas on converting patient input into meaningful performance measures.
Pharmacy Week in Review: May 19, 2017
A look at the top stories in pharmacy last week.
Biosimilars Continue Trending Upward
Jonathan Van Lare, PharmD, director of Pharmacy Advantage, discusses the growth of biosimilars in specialty pharmacy.
How Can Pharmacies Best Demonstrate Quality?
Cheryl Allen, vice president of Industry Relations at Diplomat, discusses how specialty pharmacies can differentiate themselves from the competition.
Managing Patients Through Difficult Side Effects from Specialty Drugs
Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses how specialty pharmacists can help patients manage adverse events from their treatment regimen.
How eAccess Technology Can Benefit Specialty Pharmacy
Gregory R. Morris, chief commercial officer at VirMedica, discusses the eAccess program for specialty pharmacies.
Pharmacy Week in Review: May 12, 2017
Specialty Pharmacy Aligned with ACO Goals
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies help advance the goals of accountable care organizations.
Challenges Ahead for Independent Specialty Pharmacies
Cheryl Allen, vice president of Industry Relations at Diplomat, discusses the largest challenges currently facing independent specialty pharmacies.
How Can Pharmacy Schools Optimize OTC Training for Students?
Mary M. Bridgeman, PharmD, BCPS, CGP, FASCP, clinical associate profession at the Ernesto Mario School of Pharmacy, Rutgers University, explains how pharmacy schools can optimize OTC training for students.
